| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1045.2B | ¥1054.6B | -0.9% |
| Operating Income | ¥63.3B | ¥84.3B | -24.9% |
| Ordinary Income | ¥81.9B | ¥100.2B | -18.3% |
| Net Income | ¥64.0B | ¥74.9B | -14.5% |
| ROE | 5.2% | 6.2% | - |
FY2025 Q3 (9-month cumulative) results show revenue of 104.5B yen (YoY -0.9%), operating income of 6.3B yen (YoY -24.9%), ordinary income of 8.2B yen (YoY -18.3%), and net income attributable to owners of 5.8B yen (YoY -16.2%). The company maintained near-flat revenue levels but experienced significant profit margin compression, with operating margin declining to 6.1% from 8.0% in the prior year period. Non-operating income of 2.7B yen partially offset the operating profit decline, contributing to a smaller decrease in ordinary income compared to operating income. The deterioration in profitability was driven by gross margin compression to 26.5% and elevated SG&A expenses of 21.4B yen, which together pressured bottom-line results despite stable top-line performance.
Revenue declined modestly by 0.9% YoY to 104.5B yen, reflecting mixed segment performance. Within the four reporting segments, Electronic Materials grew 8.7% to 19.4B yen, while Energy Materials contracted sharply by 27.1% to 8.3B yen. Life & Healthcare remained relatively stable at 29.0B yen (down 1.4%), and Glass segment posted slight growth of 0.2% to 43.9B yen. The Glass segment represents the largest business at 42.0% of total revenue, functioning as the core business. Other segments contributed 4.1B yen, up from 3.1B yen in the prior year. The Electronic Materials segment benefited from favorable demand conditions, while Energy Materials faced significant headwinds requiring operational adjustments.
Operating profit decreased 24.9% to 6.3B yen, reflecting substantial margin erosion. Gross profit fell to 27.7B yen with a gross margin of 26.5%, down from higher levels in the prior period. SG&A expenses of 21.4B yen represented 20.5% of revenue, indicating a fixed cost burden that weighed on operating leverage. The operating margin compression from 8.0% to 6.1% reflects both reduced gross profitability and limited expense flexibility. Non-operating income of 2.7B yen (including equity method gains and financial income) provided partial relief, resulting in ordinary income of 8.2B yen. After accounting for special items (special gains of 1.1B yen and special losses of 1.1B yen, nearly offsetting), net income attributable to owners reached 5.8B yen. This represents a revenue stable/profit down pattern, with core operational profitability under pressure despite top-line resilience.
Electronic Materials segment generated revenue of 19.4B yen (YoY +8.7%) and operating income of 3.0B yen (YoY -23.4%), resulting in an operating margin of 15.3%. The revenue expansion contrasts with profit margin compression, suggesting pricing pressure or cost inflation. Energy Materials segment recorded revenue of 8.3B yen (YoY -27.1%) and operating loss of 2.8B yen (compared to a loss of 1.3B yen in the prior year), indicating deteriorating market conditions and structural challenges requiring turnaround efforts. Life & Healthcare segment achieved revenue of 29.0B yen (YoY -1.4%) and operating income of 4.0B yen (YoY +8.7%), with a strong operating margin of 13.9% demonstrating resilient profitability. Glass segment, the largest business at 43.9B yen revenue (YoY +0.2%), posted operating income of 1.8B yen (YoY -1.3%) with an operating margin of 4.2%, reflecting a low-margin, stable business profile. The segment margin differential is material, with Life & Healthcare and Electronic Materials achieving double-digit margins while Glass operates at sub-5% margins and Energy Materials remains unprofitable. The Other category contributed 4.1B yen in revenue and 0.3B yen in operating income.
[Profitability] ROE of 4.6% remains below the manufacturing industry median of 5.2% and reflects a decline from prior performance levels. Net profit margin of 5.5% falls below the industry median of 6.4%, while operating margin of 6.1% significantly trails the industry median of 8.7%, indicating profitability challenges across both operational and net income levels. [Cash Quality] Cash and deposits of 22.5B yen provide coverage of 3.9 times against short-term borrowings of 5.8B yen, ensuring adequate liquidity. The current ratio of 212.1% exceeds the industry median of 283%, while the quick ratio of 158.1% demonstrates solid short-term payment capacity. [Investment Efficiency] Total asset turnover of 0.515 lags the industry median of 0.58, reflecting lower asset productivity. ROIC of 4.3% falls below the industry median of 6.0%, highlighting capital efficiency challenges. Inventory turnover period of 137.4 days substantially exceeds the industry median of 108.8 days, while receivables turnover of 85.2 days compares to the industry median of 82.9 days, indicating working capital inefficiencies. [Financial Health] Equity ratio of 61.1% aligns with the industry median of 63.8%, representing sound capitalization. Debt-to-equity ratio of 0.11 and net debt-to-EBITDA of negative 0.76 indicate conservative leverage, well below median debt levels. Interest coverage of 33.3 times provides substantial cushion for debt service. However, short-term debt comprises 44.0% of total interest-bearing liabilities, warranting attention to refinancing management.
Cash and deposits increased 11.8B yen YoY to 22.5B yen, representing accumulation from operating activities and asset management. Total assets decreased modestly to 202.9B yen from 204.8B yen, primarily reflecting a 4.2B yen reduction in long-term borrowings and working capital adjustments. Accounts receivable increased 4.0B yen to 25.6B yen, consistent with revenue maintenance but extending collection periods to 85.2 days above historical norms. Inventories rose 2.9B yen to 36.3B yen, contributing to elevated inventory days of 137.4 and suggesting production-demand misalignment or strategic stockpiling. Accounts payable decreased 0.1B yen to 33.4B yen, with payables turnover of 111.1 days exceeding the industry median of 55.8 days, indicating extended supplier payment terms. The working capital cycle (cash conversion cycle) extended to 111.5 days, above the industry median of 108.1 days and reflecting tied-up capital in operations. Contract liabilities of 1.3B yen represent advance payments from customers, providing working capital support. Cash coverage of current liabilities stands at 4.3%, with the substantial current asset base of 111.0B yen providing 2.1 times coverage of current liabilities of 52.4B yen, ensuring adequate near-term liquidity despite working capital extension.
Ordinary income of 8.2B yen versus operating income of 6.3B yen reflects net non-operating income contribution of approximately 1.9B yen, representing 1.8% of revenue. Primary components include equity method investment gains and financial income from interest and dividends. The moderate non-operating contribution does not materially distort core earnings assessment. Special items included gains of 1.1B yen and losses of 1.1B yen, effectively neutralizing on a net basis. Investment securities sales contributed to special gains, indicating portfolio management activity but not representing recurring income. The gap between ordinary income and operating income remained within normal parameters at 29.5%, suggesting earnings quality is not significantly enhanced by non-core items. Without disclosed operating cash flow data, the traditional OCF-to-net-income comparison cannot be performed. However, the working capital expansion evidenced by increased receivables and inventories against stable revenue suggests potential cash flow pressure and earnings quality concerns, as accrual-based profits may not be fully converting to cash. The elevated inventory and receivables balances warrant monitoring for potential write-down risk or collection issues that could impact future earnings quality.
Full-year guidance projects revenue of 143.2B yen, operating income of 8.1B yen, ordinary income of 9.3B yen, and net income of 6.3B yen. Q3 cumulative progress rates stand at 73.0% for revenue, 78.2% for operating income, 88.1% for ordinary income, and 91.3% for net income attributable to owners. The ordinary income and net income progress rates significantly exceed the standard 75% benchmark for Q3, suggesting strong seasonal performance in the first nine months with potential deceleration expected in Q4. The operating income progress rate of 78.2% indicates slightly ahead-of-schedule performance but implies Q4 operating income of approximately 1.8B yen, below the 2.1B yen average of prior quarters. The guidance reflects YoY declines of 0.7% in revenue, 23.8% in operating income, and 23.6% in ordinary income, consistent with the profit margin compression observed in Q3 results. The EPS forecast of 254.15 yen implies full-year earnings capacity below the Q3 cumulative run rate of 232.23 yen per quarter, confirming anticipated Q4 profit moderation.
Annual dividend of 85 yen per share is maintained, consisting of an interim dividend of 85 yen already paid. Based on Q3 cumulative EPS of 232.23 yen and full-year EPS guidance of 254.15 yen, the implied payout ratio approximates 33.5% on a full-year basis. Using the Q3 cumulative net income attributable to owners of 5.8B yen and total shares outstanding of approximately 24.8 million, the 85 yen per share dividend represents a total payout of approximately 2.1B yen, yielding a payout ratio of 36.5% based on Q3 performance. This moderate payout ratio provides room for dividend sustainability and potential increases, contrasting with the earlier estimated 76.8% ratio which appears to reflect annualized Q3 results rather than full-year guidance. No share buyback activity is disclosed in the current period. The stable dividend policy demonstrates management commitment to shareholder returns while maintaining financial flexibility for business investment and working capital needs.
Demand volatility across diverse end markets including electronics, energy materials, life sciences, and glass applications creates revenue unpredictability. Segment performance divergence, particularly the 27.1% revenue decline and deepening losses in Energy Materials, indicates exposure to sector-specific cyclical downturns requiring restructuring or strategic repositioning. Working capital management deterioration poses significant cash flow risk. Inventory days of 137.4 and receivables days of 85.2, both elevated versus industry norms, tie up approximately 22.9B yen in excess working capital that could otherwise support investment or debt reduction. Extended working capital cycles compress cash conversion and reduce financial flexibility. Raw material and energy cost inflation remains a structural risk for chemical and glass manufacturing operations. With gross margin compression evident at 26.5%, the company demonstrates limited pricing power to offset input cost increases, particularly in lower-margin segments like Glass (4.2% operating margin) where competitive dynamics constrain price recovery.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics trail industry medians across key measures. ROE of 4.6% falls below the manufacturing industry median of 5.2% (Q3 2025, n=100 companies), indicating below-average shareholder return generation. Operating margin of 6.1% significantly underperforms the industry median of 8.7%, while net profit margin of 5.5% lags the median of 6.4%, reflecting margin pressure relative to manufacturing peers. ROIC of 4.3% trails the industry median of 6.0%, suggesting suboptimal capital deployment efficiency.
Financial health indicators present mixed positioning. The equity ratio of 61.1% approximates the industry median of 63.8%, demonstrating sound capitalization in line with sector norms. The current ratio of 212.1% falls below the industry median of 283.0%, though still indicates adequate short-term liquidity. Conservative leverage profile with net debt-to-EBITDA of negative 0.76 compares favorably to the industry median of negative 1.11, indicating a stronger balance sheet position than typical manufacturing peers.
Efficiency metrics highlight operational challenges. Asset turnover of 0.515 underperforms the industry median of 0.58, reflecting lower sales productivity per yen of assets. Working capital management shows inefficiency with inventory turnover of 137.4 days exceeding the industry median of 108.8 days by 26%, while operating working capital turnover of 111.5 days aligns with the industry median of 108.1 days. Revenue growth of negative 0.9% trails the industry median of positive 2.8%, positioning the company as a below-average growth performer within the manufacturing sector.
※ Industry: Manufacturing (100 companies), Comparison: Q3 2025 fiscal periods, Source: Proprietary analysis
Operating margin compression from 8.0% to 6.1% represents the most significant earnings characteristic, driven by gross margin deterioration and fixed cost burden against flat revenue. This 190 basis point margin decline translated to a 24.9% operating profit decrease despite revenue declining only 0.9%, demonstrating high operating leverage working in reverse. The trend indicates structural profitability challenges requiring cost management initiatives or pricing power recovery to restore historical margin levels.
Working capital inefficiency emerged as a critical operational trend, with inventory days extending to 137.4 and cash conversion cycle reaching 111.5 days. The 2.9B yen YoY inventory increase and 4.0B yen receivables growth against flat revenue suggest demand forecasting challenges or customer payment extension. This working capital expansion constrains cash generation capacity and reduces financial flexibility for growth investment or shareholder returns enhancement.
Segment performance divergence highlights portfolio quality concerns. While Life & Healthcare delivered 8.7% operating profit growth on stable revenue with 13.9% margins, Energy Materials losses deepened to 2.8B yen from 1.3B yen despite the company's segment restructuring efforts. Electronic Materials revenue grew 8.7% but operating profit declined 23.4%, indicating margin pressure from competitive dynamics or unfavorable product mix. The Glass core business maintained revenue stability but operates at low 4.2% margins with limited improvement trajectory, suggesting limited earnings growth potential from the largest segment absent significant operational transformation.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.